Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Gallinamide A TFA | 1352920-57-0 | 706.79 | 1 MG
SDP

Catalog No. 5000415581
Encompass_Preferred

Gallinamide A TFA is a linearly depositing peptide and a potent inhibitor of cathepsin L (CatL) with an IC50 of 17.6 pM. It inhibits SARS-CoV-2 infection by inhibiting CatL (EC50: 28 nM) and also inhibits Plasmodium falciparum (IC50: 50 nM). It is for research use only and not sold to patients.

  • Inhibits cathepsin L, B, V, K, and S.
  • Effective against SARS-CoV-2 infection.
  • Inhibits P. falciparum.
  • Exhibits low cytotoxicity in VeroE6 cells.
  • Shows synergistic effects with TMPRSS2 inhibitor Nafamostat.

Catalog No. 50-004-15581 Supplier Medchemexpress LLC Supplier No. HYN10109A1MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Gallinamide A TFA is a linearly depositing peptide and a potent inhibitor of cathepsin L (CatL) with an IC50 of 17.6 pM. It inhibits SARS-CoV-2 infection by inhibiting CatL (EC50: 28 nM) and also inhibits Plasmodium falciparum (IC50: 50 nM). It is for research use only and not sold to patients.

  • Inhibits cathepsin L, B, V, K, and S.
  • Effective against SARS-CoV-2 infection.
  • Inhibits P. falciparum.
  • Exhibits low cytotoxicity in VeroE6 cells.
  • Shows synergistic effects with TMPRSS2 inhibitor Nafamostat.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.